 SHANGHAI and SAN FRANCISCO, April 20, 2021 GLOBE NEWSWIRE -- Zai Lab Limited Zai Lab or the Company NASDAQ:ZLAB, HKEX: 9688, an innovative commercial stage biopharmaceutical company, today announced the pricing of its underwritten public offering of 4,776,000 American depositary shares ADSs, each representing one ordinary share of the Company, at a price of US150.00 per ADS, and 224,000 ordinary shares, at a price of HK1164.20 per ordinary share, which will be settled in Hong Kong dollars, based upon each ADS representing one ordinary share and an exchange rate of HK7.7613 to US1.00, the spot rate of exchange at the time of pricing. 